Projects per year
Personal profile
Biography
Dr Mary Lou Chatterton is a Senior Research Fellow and Co-Program Lead for Mental Health in Monash University Health Economics Group, one of the largest groups of health economists dedicated to mental health. She has a doctorate in clinical pharmacy and completed a two-year pharmacoeconomic research training fellowship. Her research focuses on economic evaluations of medications, psychological interventions, and novel delivery systems to prevent and treat mental health conditions including bipolar disorder, schizophrenia, anxiety and depression.
Research area keywords
- Health Economics
- Mental Health
- Clinical Trials
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 12 Responsible Consumption and Production -
SDG 13 Climate Action
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Economic Modelling and Evaluation of Mental Health Interventions
Mihalopoulos, C. (Primary Chief Investigator (PCI)), Hamilton, M. (Chief Investigator (CI)), Le, L. (Chief Investigator (CI)), Lee, Y. Y. (Chief Investigator (CI)), Tan, A. (Chief Investigator (CI)), Ride, J. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Engel, L. (Chief Investigator (CI)), Bellgrove, M. (Chief Investigator (CI)) & Hewitt, D. (Chief Investigator (CI))
23/03/26 → 30/06/27
Project: Research
-
CALM-Kids: Co-design and evaluation of family-based lifestyle therapy versus placebo control for reducing child anxiety
Olive, L. (Primary Chief Investigator (PCI)), O'Neil, A. (Chief Investigator (CI)), Stubbs, B. (Chief Investigator (CI)), Jacka, F. N. (Chief Investigator (CI)), Telford, R. M. (Chief Investigator (CI)), Staudacher, H. (Chief Investigator (CI)), Hoare, E. (Chief Investigator (CI)), Berk, M. (Chief Investigator (CI)), O'Shea, M. (Chief Investigator (CI)), Lotfaliany, M. (Chief Investigator (CI)), Chatterton, M. L. (Chief Investigator (CI)), Vuillermin, P. (Associate Investigator (AI)), Milroy, H. (Associate Investigator (AI)), Marx, W. (Associate Investigator (AI)), Prague, M. (Associate Investigator (AI)), Kneebone-Bates, M. (Associate Investigator (AI)) & Chapman, A. (Chief Investigator (CI))
Department of Health, Disability and Ageing (Australia)
1/07/25 → 30/06/27
Project: Research
-
Reconceptualising Neurodevelopment and Psychopathology to Improve Healthcare for Children and Youth
Johnson, B. (Primary Chief Investigator (PCI)), Tiego, J. (Chief Investigator (CI)), Forbes, M. (Chief Investigator (CI)), Boulton , K. (Chief Investigator (CI)), Brignell, A. (Chief Investigator (CI)), Ure, A. (Chief Investigator (CI)), Richmond, S. (Chief Investigator (CI)), Kerestes, R. (Chief Investigator (CI)), Rabba, A. S. (Chief Investigator (CI)), Lee, Y. Y. (Chief Investigator (CI)), Morris, H. (Chief Investigator (CI)), Bellgrove, M. (Associate Investigator (AI)), Williams, K. (Associate Investigator (AI)), Guastella, A. J. (Associate Investigator (AI)), Basu, S. (Associate Investigator (AI)), Loth, E. (Associate Investigator (AI)), Lawrence, K. (Associate Investigator (AI)), Coghill, D. (Associate Investigator (AI)), Mosconi, M. W. (Associate Investigator (AI)), Byrne, M. (Associate Investigator (AI)), Chatterton, M. L. (Associate Investigator (AI)) & Wybrow, M. (Associate Investigator (AI))
1/04/25 → 31/03/30
Project: Research
-
PCEP: Evaluation of the Primary Care Enhancement Program (Phase 2)
Boyle, F. M. (Primary Chief Investigator (PCI)), Chatterton, M. L. (Chief Investigator (CI)) & Lee, Y. Y. (Chief Investigator (CI))
7/03/25 → 31/07/26
Project: Research
-
PRevention of Mental Illness and Substance usE (PREMISE) Next Generation: New Targets, New Interventions
Slade, T. (Primary Chief Investigator (PCI)), Newton, N. C. (Chief Investigator (CI)), Chapman, C. (Chief Investigator (CI)), Calear, A. L. (Chief Investigator (CI)), Hudson, J. (Chief Investigator (CI)), Hides, L. (Chief Investigator (CI)), Olsson, C. A. (Chief Investigator (CI)), Squeglia, L. (Chief Investigator (CI)), Mihalopoulos, C. (Chief Investigator (CI)), Teesson, M. (Chief Investigator (CI)) & Chatterton, M. L. (Associate Investigator (AI))
1/11/24 → 30/10/29
Project: Research
-
Cost-Utility Analysis of a School-Based Universal Program for the Prevention of Anxiety, Depression, and Substance Use: The Climate Schools Combined Trial
Chatterton, M. L., Perez, J. K., Lee, Y. Y., Le, L. K. D., Birrell, L., Slade, T., Mewton, L., Hides, L., McBride, N., Allsop, S., Furneaux-Bate, A., Bryant, Z., Ellem, R., Baker, M. J., Quinn, C., Chapman, C., Newton, N. C., Teesson, M. & Mihalopoulos, C., Feb 2026, In: International Journal of Mental Health and Addiction. 24, 1, p. 510–528 19 p.Research output: Contribution to journal › Article › Research › peer-review
1 Link opens in a new tab Citation (Scopus) -
RETRACTION: Effect of ketamine on anxiety: Findings from the Ketamine for Adult Depression Study (The British Journal of Psychiatry (2025) 227 (601–607) DOI: 10.1192/bjp.2024.250)
Mills, N. T., Nikolin, S., Glozier, N., Barton, D., Baune, B. T., Fitzgerald, P. B., Glue, P., Sarma, S., Rodgers, A., Hadzi-Pavlovic, D., Alonzo, A., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M. L., Somogyi, A. A., Mihalopoulos, C. & Chatterton, M. L. & 2 others, , 2026, (Accepted/In press) In: The British Journal of Psychiatry. 1 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Addressing the unmet needs of bipolar disorder in Australia and beyond
Cotton, S. M., Hasty, M., Mitchell, P., Murray, G., Hickie, I. B., McGorry, P. D., Walder, K., Dean, O. M., Mihalopoulos, C., Yung, A. R., Van Rheenen, T. E., Nierenberg, A. A., Scott, J., Williams, L. J., Berk, L., Davey, C. G., Crouse, J. J., Scott, E., Iorfino, F. & Filia, K. & 6 others, , Nov 2025, In: Australian and New Zealand Journal of Psychiatry. 59, 11, p. 957-965 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
An Updated Systematic Literature Review of the Economic Costs of Loneliness and Social Isolation and the Cost Effectiveness of Interventions
Engel, L. (Leading Author), Rizal, M. F., Clifford, S., Faller, J., Lim, M. H., Le, L. K. D., Chatterton, M. L. & Mihalopoulos, C., Sept 2025, In: PharmacoEconomics. 43, 9, p. 1047–1063 17 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access12 Link opens in a new tab Citations (Scopus) -
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial – The KADS study
Chatterton, M. L., Perez, J. K., Thai, T., Faller, J., Loo, C. K., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P. B., Glue, P., Sarma, S., Hadzi-Pavlovic, D., Dong, V., Martin, D., Mitchell, P. B., Berk, M., Carter, G., Hackett, M. & Hood, S. & 3 others, , 15 Oct 2025, In: Journal of Affective Disorders. 387, 10 p., 119502.Research output: Contribution to journal › Article › Research › peer-review
3 Link opens in a new tab Citations (Scopus)
Prizes
-
2023: Australian Clinical Trials Alliance HEAT Excellence in Trial Based Health Economics Award
Mihalopoulos, C. (Recipient), Chatterton, M. L. (Recipient) & Lee, Y. Y. (Recipient), 27 Nov 2023
Prize: Prize (including medals and awards)